AAPS 2014 San Diego

Continuous manufacturing can go anywhere in the world by boat or helicopter, says Pfizer's expert

Pfizer hails portable manufacturing as latest in lean

By Fiona Barry

How can a pharma company invest in continuous manufacturing without bleeding money when it retreats from a local market? Pfizer’s answer is production pods it can roll out anywhere in the world via helicopter… and pack away again if a market turns.

University of Texas has spent seven years developing a nasal spray vaccine against Ebola


Ebola nasal vaccine under threat as funding runs dry

By Dan Stanton

Lack of funding is threatening development of a nasal spray vaccine shown to provide long-term protection for non-human primates against the Ebola virus, the lead researcher told this publication in an exclusive interview.

Protective equipment for health workers in Guinea. (Picture: EC/ECHO/Jean-Louis Mosser)

Dispatches from AAPS 2014

BARDA: Ebola is “a bioterrorism threat”

By Fiona Barry

BARDA, the US government’s Biomedical Advanced Research and Development Authority, has revealed it sees Ebola “as a bioterrorism threat.”